Evidence map›Paper›PMID 23817579›Full record

ArticleImmunology and cell biology2013

Host genetic background impacts modulation of the TLR4 pathway by RON in tissue-associated macrophages.

Amitabha Chaudhuri, Nicholas S Wilson, Becky Yang, Andres Paler Martinez, Jinfeng Liu, Catherine Zhu, Nicole Bricker, Suzana Couto, Zora Modrusan, Dorothy French and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Immunology and cell biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A network map of macrophage-stimulating protein (MSP) signaling.Journal of cell communication and signaling · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Amitabha ChaudhuriDepartment of Molecular Oncology, Genentech Inc., South San Francisco, CA 94080, USA.
Nicholas S Wilson
Becky Yang
Andres Paler Martinez
Jinfeng Liu
Catherine Zhu
Nicole Bricker
Suzana Couto
Zora Modrusan
Dorothy French
James Cupp
Avi Ashkenazi
Molecular Oncology (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toll-like receptors (TLRs) enable metazoans to mount effective innate immune responses to microbial and viral pathogens, as well as to endogenous host-derived ligands. It is understood that genetic background of the host can influence TLR responsiveness, altering susceptibility to pathogen infection, autoimmunity and cancer. Macrophage stimulatory protein (MSP), which activates the receptor tyrosine kinase recepteur d'origine nantais (RON), promotes key macrophage functions such as motility and phagocytic activity. MSP also acts via RON to modulate signaling by TLR4, which recognizes a range of pathogen or endogenous host-derived molecules. Here, we show that RON exerts divergent control over TLR4 activity in macrophages from different mouse genetic backgrounds. RON potently modulated the TLR4 response in macrophages from M2-prone FVB mice, as compared with M1-skewed C57Bl6 mice. Moreover, global expression analysis revealed that RON suppresses the TLR4-dependent type-I interferon gene signature only in FVB macrophages. This leads to attenuated production of the potent inflammatory mediator, tumor necrosis factor-α. Eliminating RON kinase activity markedly decreased carcinogen-mediated tumorigenesis in M2/Th2-biased FVB mice. We propose that host genetic background influences RON function, thereby contributing to the variability in TLR4 responsiveness in rodents and, potentially, in humans. These findings provide novel insight into the complex interplay between genetic context and immune function.

Indexed as

9,10-Dimethyl-1,2-benzanthraceneAnimalsCarcinogenesisCell MovementFibrosarcomaGenotypeHepatocyte Growth FactorInterferon Type IMacrophages, PeritonealMethylcholanthreneMiceMice, Inbred C57BLMice, KnockoutPapillomaProto-Oncogene ProteinsReceptor Protein-Tyrosine Kinases9,10-Dimethyl-1,2-benzanthraceneHepatocyte Growth FactorInterferon Type Imacrophage stimulating proteinMethylcholanthreneProto-Oncogene ProteinsReceptor Protein-Tyrosine KinasesRON proteinToll-Like Receptor 4

Identifiers

PMID23817579
PMCPMC3736205
OpenAlexW2084494435

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.